| Tabrecta 150 mg film-coated tablets EU/1/22/1650/001-002 |
Capmatinib dihydrochloride monohydrate |
Novartis Europharm Limited |
— |
| Tabrecta 200 mg film-coated tablets EU/1/22/1650/003-004 |
Capmatinib dihydrochloride monohydrate |
Novartis Europharm Limited |
— |
| Tacforius 0.5 mg Prolonged-release capsule, hard EU/1/17/1244/001-006 |
Tacrolimus monohydrate |
Teva B.V. |
— |
| Tacforius 1 mg Prolonged-release capsule, hard EU/1/17/1244/007-014 |
Tacrolimus monohydrate |
Teva B.V. |
— |
| Tacforius 3 mg Prolonged-release capsule, hard EU/1/17/1244/015-020 |
Tacrolimus monohydrate |
Teva B.V. |
— |
| Tacforius 5 mg Prolonged-release capsule, hard EU/1/17/1244/021-026 |
Tacrolimus monohydrate |
Teva B.V. |
— |
| TachoSil sealant matrix EU/1/04/277/1-4 |
Fibrinogen |
Corza Medical GmbH |
— |
| Tacrolimus 0.03% ointment PA2315/269/001 |
Tacrolimus |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Tacrolimus 0.1% Ointment PA2315/120/001 |
Tacrolimus |
Accord Healthcare Ireland Ltd. |
Marketed |
| Tadalafil 10mg film-coated tablets PA22749/020/003 |
Tadalafil |
Brillpharma (Ireland) Limited |
Not marketed |
| Tadalafil 10mg Film-coated Tablets PA2315/071/002 |
Tadalafil |
Accord Healthcare Ireland Ltd. |
Marketed |
| Tadalafil 2.5mg film-coated tablets PA22749/020/001 |
Tadalafil |
Brillpharma (Ireland) Limited |
Not marketed |
| Tadalafil 20 mg film-coated tablets PA2315/071/003 |
Tadalafil |
Accord Healthcare Ireland Ltd. |
Marketed |
| Tadalafil 20 mg film-coated tablets PA22865/012/002 |
Tadalafil |
Renata Pharmaceuticals (Ireland) Limited |
Not marketed |
| Tadalafil 20mg film-coated tablets PA22749/020/004 |
Tadalafil |
Brillpharma (Ireland) Limited |
Not marketed |
| Tadalafil 5 mg film-coated tablets PA22865/012/001 |
Tadalafil |
Renata Pharmaceuticals (Ireland) Limited |
Not marketed |
| Tadalafil 5mg film-coated tablets PA22749/020/002 |
Tadalafil |
Brillpharma (Ireland) Limited |
Not marketed |
| Tadalafil Clonmel 10 mg film-coated tablets PA0126/311/001 |
Tadalafil |
Clonmel Healthcare Ltd |
Marketed |
| Tadalafil Clonmel 10 mg film-coated tablets PA0126/380/001 |
Tadalafil |
Clonmel Healthcare Ltd |
Not marketed |
| Tadalafil Clonmel 20 mg film-coated tablets PA0126/311/002 |
Tadalafil |
Clonmel Healthcare Ltd |
Marketed |
| Tadalafil Krka 10 mg film-coated tablets PA1347/071/003 |
Tadalafil |
KRKA, d.d., Novo mesto |
Marketed |
| Tadalafil Krka 2.5 mg film-coated tablets PA1347/071/001 |
Tadalafil |
KRKA, d.d., Novo mesto |
Not marketed |
| Tadalafil Krka 20 mg film-coated tablets PA1347/071/004 |
Tadalafil |
KRKA, d.d., Novo mesto |
Marketed |
| Tadalafil Krka 5 mg film-coated tablets PA1347/071/002 |
Tadalafil |
KRKA, d.d., Novo mesto |
Not marketed |
| Tadalafil Lilly 10 mg film-coated tablets EU/1/17/1177/005 |
Tadalafil |
Eli Lilly Nederland B.V. |
— |
| Tadalafil Lilly 2.5 mg film-coated tablets EU/1/17/1177/001 |
Tadalafil |
Eli Lilly Nederland B.V. |
— |
| Tadalafil Lilly 20 mg film-coated tablets EU/1/17/1177/006-009 |
Tadalafil |
Eli Lilly Nederland B.V. |
— |
| Tadalafil Lilly 5 mg film-coated tablets EU/1/17/1177/002-004 |
Tadalafil |
Eli Lilly Nederland B.V. |
— |
| Tadalafil Mylan 10 mg film-coated tablets EU/1/14/961/001 |
Tadalafil |
Mylan Pharmaceuticals Limited |
— |
| Tadalafil Mylan 2.5 mg film-coated tablets EU/1/14/961/008-009 |
Tadalafil |
Mylan Pharmaceuticals Limited |
— |
| Tadalafil Mylan 20 mg film-coated tablets EU/1/14/961/002-006 |
Tadalafil |
Mylan Pharmaceuticals Limited |
— |
| Tadalafil Mylan 5 mg film-coated tablets EU/1/14/961/012-017 |
Tadalafil |
Mylan Pharmaceuticals Limited |
— |
| Tafinlar 50 mg hard capsules EU/1/13/865/001-002 |
Dabrafenib |
Novartis Europharm Limited |
— |
| Tafinlar 75 mg hard capsules EU/1/13/865/003-004 |
Dabrafenib |
Novartis Europharm Limited |
— |
| TAGRISSO 40 mg film-coated tablets EU/1/16/1086/001 |
Osimertinib mesylate |
AstraZeneca AB |
— |
| TAGRISSO 80 mg film-coated tablets EU/1/16/1086/002 |
Osimertinib mesylate |
AstraZeneca AB |
— |
| TAKHZYRO 150 mg solution for injection in pre-filled syringe EU/1/18/1340/007-009 |
LANADELUMAB |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| TAKHZYRO 300 mg solution for injection EU/1/18/1340/001 |
LANADELUMAB |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Talmanco 20 mg film-coated tablets EU/1/16/1153/001-004 |
Tadalafil |
Viatris Limited |
— |
| Taltz 40mg Solution for injection EU/1/15/1085/007 |
Ixekizumab |
Eli Lilly Kinsale Limited |
— |
| Taltz 80 mg solution for injection in pre-filled pen EU/1/15/1085/001-003 |
Ixekizumab |
Eli Lilly Kinsale Limited |
— |
| Taltz 80 mg solution for injection in pre-filled syringe EU/1/15/1085/004-006 |
Ixekizumab |
Eli Lilly Kinsale Limited |
— |
| TALVEY 2 mg/mL solution for injection EU/1/23/1748/001 |
Talquetamab |
Janssen-Cilag International NV |
— |
| TALVEY 40 mg/mL solution for injection EU/1/23/1748/002 |
Talquetamab |
Janssen-Cilag International NV |
— |
| Talzenna 0.1 mg Capsule, hard EU/1/19/1377/007 |
TALAZOPARIB TOSYLATE |
Pfizer Europe MA EEIG |
— |
| Talzenna 0.25 mg Capsule, hard EU/1/19/1377/001-004 |
TALAZOPARIB TOSYLATE |
Pfizer Europe MA EEIG |
— |
| Talzenna 0.35 mg hard capsules EU/1/19/1377/008 |
Talazoparib tosilate |
Advanz Pharma Limited |
— |
| Talzenna 0.5 mg hard capsules EU/1/19/1377/009 |
Talazoparib tosilate |
Pfizer Europe MA EEIG |
— |
| Talzenna 1 mg Capsule, hard EU/1/19/1377/005-006 |
TALAZOPARIB TOSYLATE |
Pfizer Europe MA EEIG |
— |
| Tambocor 10 mg/ml Solution for Injection or Infusion PA23355/023/001 |
Flecainide acetate |
Viatris Healthcare Limited |
Marketed |